JP2004534813A5 - - Google Patents

Download PDF

Info

Publication number
JP2004534813A5
JP2004534813A5 JP2003506887A JP2003506887A JP2004534813A5 JP 2004534813 A5 JP2004534813 A5 JP 2004534813A5 JP 2003506887 A JP2003506887 A JP 2003506887A JP 2003506887 A JP2003506887 A JP 2003506887A JP 2004534813 A5 JP2004534813 A5 JP 2004534813A5
Authority
JP
Japan
Prior art keywords
cellobiose
carrier
pharmaceutical composition
powder
inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003506887A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004534813A (ja
JP4348179B2 (ja
Filing date
Publication date
Priority claimed from US09/885,349 external-priority patent/US6482429B1/en
Application filed filed Critical
Publication of JP2004534813A publication Critical patent/JP2004534813A/ja
Publication of JP2004534813A5 publication Critical patent/JP2004534813A5/ja
Application granted granted Critical
Publication of JP4348179B2 publication Critical patent/JP4348179B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003506887A 2001-06-20 2002-06-11 安定な粉末吸入投与組成物 Expired - Lifetime JP4348179B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/885,349 US6482429B1 (en) 2001-06-20 2001-06-20 Stable powder inhalation dosage formulation
PCT/US2002/018406 WO2003000240A2 (en) 2001-06-20 2002-06-11 Stable powder inhalation dosage formulation

Publications (3)

Publication Number Publication Date
JP2004534813A JP2004534813A (ja) 2004-11-18
JP2004534813A5 true JP2004534813A5 (https=) 2006-01-05
JP4348179B2 JP4348179B2 (ja) 2009-10-21

Family

ID=25386707

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003506887A Expired - Lifetime JP4348179B2 (ja) 2001-06-20 2002-06-11 安定な粉末吸入投与組成物

Country Status (9)

Country Link
US (1) US6482429B1 (https=)
EP (1) EP1401409B1 (https=)
JP (1) JP4348179B2 (https=)
AT (1) ATE459346T1 (https=)
CA (1) CA2446221C (https=)
DE (1) DE60235544D1 (https=)
ES (1) ES2339751T3 (https=)
MX (1) MXPA03011517A (https=)
WO (1) WO2003000240A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9408499D0 (en) 1994-04-28 1994-06-22 Edwin Shirley Trucking Limited A releasable joint for joining two construction elements of a transportable stage assembly
TR200402367T4 (tr) * 2000-10-12 2004-12-21 Boehringer Ingelheim Pharma Gmbh& Co.Kg Yeni tiotropyum içeren inhalasyon tozları
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US6620438B2 (en) * 2001-03-08 2003-09-16 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
KR101007151B1 (ko) * 2002-04-04 2011-01-13 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 흡입용 분말 제형
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
AU2004291542A1 (en) * 2003-11-18 2005-06-02 Yansong Shan Healthy pleasurable inhalation device
WO2005065185A2 (en) * 2003-12-24 2005-07-21 Collegium Pharmaceuticals, Inc. Temperature-stable formulations, and methods of development thereof
JP5001847B2 (ja) * 2005-09-27 2012-08-15 旭化成ケミカルズ株式会社 セロオリゴ糖含有組成物
WO2008021451A2 (en) * 2006-08-14 2008-02-21 Aktiv-Dry Llc Human-powered dry powder inhaler and dry powder inhaler compositions
TR201007250A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Selobioz içeren formülasyon.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5846516A (en) * 1992-06-03 1998-12-08 Alliance Pharmaceutial Corp. Perfluoroalkylated amphiphilic phosphorus compounds: preparation and biomedical applications
SE9203743D0 (sv) * 1992-12-11 1992-12-11 Astra Ab Efficient use
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
WO2002015880A2 (en) * 2000-08-25 2002-02-28 Merck Patent Gmbh Powdered mannitol and mannitol-containing compositions

Similar Documents

Publication Publication Date Title
JP2004534813A5 (https=)
JP2007106777A5 (https=)
JP3567329B2 (ja) 吸入散剤及びその製造方法
CA2369726A1 (en) Powder inhaler for combined medicament
WO2007123955A3 (en) Stable hydroalcoholic oral spray formulations and methods
CA2395653A1 (en) New inhalable powder containing tiotropium
JP2011520911A5 (https=)
JP2013534227A5 (https=)
JP2002538110A5 (https=)
CA2369722A1 (en) Powder inhaler for combined medicament
IL118986A (en) Optically pure epitropium salts and pharmaceutical preparations containing them
WO2001095874A2 (en) Highly efficient delivery of a large therapeutic mass aerosol
JP2014509313A5 (https=)
JP2020527377A5 (https=)
RU2007124795A (ru) Медицинский продукт, содержащий лекарственное средство на основе глюкагоноподобного пептида, предназначенное для легочной ингаляции
RU2006112589A (ru) Фармацевтические композиции для лечения преждевременной эякуляции при помощи легочной ингаляции
CA2405767A1 (en) Pharmaceutical formulations for dry powder inhalers
BR0317443A (pt) Medicamento pulverulento para inalação contendo um sal de tiotrópio e xinafoato de salmeterol
JP2002529396A5 (https=)
JP2011157405A5 (https=)
JP2016515576A5 (https=)
JP2013541565A5 (https=)
WO2009112274A3 (en) Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
JP2015519356A5 (https=)
MX2014007358A (es) Inhalador que comprende una composicion que contiene tiotropio.